• DOI:10.1080/00048670701449237
Corpus ID: 25832516

Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk

@article{Silins2007QualitativeRO,
  title={Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk},
  author={E. Silins and J. Copeland and P. Dillon},
  journal={Australian and New Zealand Journal of Psychiatry},
  year={2007},
  volume={41},
  pages={649 - 655}
}

E. Silins, J. Copeland, P. Dillon

Published 2007

Psychology, Medicine

Australian and New Zealand Journal of Psychiatry

Growth of the antidepressant market and widespread use of the illicit drug ecstasy (methylenedioxymethamphetamine; MDMA) creates a need to delineate the potential harms associated with the concomitant use of ecstasy and serotonergic pharmaceutical drugs. One such harm is serotonin syndrome. The study aimed to synthesize the risk of serotonin syndrome associated with the concomitant use of ecstasy and other serotonergic substances in a clinically relevant hierarchy for psychiatrists and other… CONTINUE READING

View on SAGE

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed